Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Abiogen Pharma Acquires German Pharmaceutical Company, Altamedics
Abiogen Pharma has completed the acquisition of the German pharmaceutical distribution company Altamedics GmbH which […]
Generate Biomedicines Demonstrates a Novel Method of Reducing Immunogenicity through Protein Re-surfacing
Generate Biomedicines has announced that it has published data in the peer-reviewed journal Frontiers in […]
Tomorrow Health Fully Automates Order Lifecycle For Full Spectrum Of Durable Medical Equipment
Tomorrow Health, a healthcare technology company enabling more efficient and reliable home-based care, has announced […]
Hansa Biopharma Announces Reimbursement in Italy for Idefirix as Desensitization Treatment for Highly Sensitized Patients in Kidney Transplantation
Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, has announced that the […]
BRIM Biotechnology Receives FDA Orphan Drug Designation for BRM424 to Treat Neurotrophic Keratitis
BRIM Biotechnology is pleased to announce that the US Food and Drug Administration (FDA) has […]
ExPLoRNA Therapeutics Receives Funding to Advance its Novel mRNA Technology
ExPLoRNA Therapeutics, a Polish biotech company revolutionizing mRNA vaccines and therapeutics with unprecedented translational efficiency, […]
Accord Healthcare Adds Generic Drug for Use in Treating Leukemia and Non-Hodgkin's Lymphoma
Accord Healthcare, a leading generic pharmaceutical company, has added Bendamustine Lyo Injection to its line […]
Ankyra Therapeutics Appoints Leisha A. Emens, M.D., Ph.D., as Senior Vice President, Translational Research
Ankyra Therapeutics, a biotech company developing targeted immune-activating agents for the treatment of cancer, today […]
GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification
GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering […]
Essential Pharma Announces the Acquisition of HALDOL
Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more